Help With Medicare Costs: What You Need to Knownews2022-05-20T17:02:07+00:00May 20th, 2022|The New York Times|
Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelmnews2022-05-03T18:00:36+00:00May 3rd, 2022|The New York Times|
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trialsnews2022-04-07T23:32:59+00:00April 7th, 2022|The New York Times|
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drugnews2022-04-06T18:43:00+00:00April 6th, 2022|The New York Times|
Financial Planning for People With Chronic Diseasesnews2022-01-14T10:00:26+00:00January 14th, 2022|The New York Times|
Medicare Proposes to Sharply Limit Coverage of the Alzheimer’s Drug Aduhelmnews2022-01-12T01:22:10+00:00January 12th, 2022|The New York Times|
Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decisionnews2021-12-31T21:39:22+00:00December 31st, 2021|The New York Times|
How to Cope With Medicare’s Rising Costsnews2021-12-22T10:00:19+00:00December 22nd, 2021|The New York Times|
How to Cope With Medicare’s Rising Costsnews2021-12-22T10:00:19+00:00December 22nd, 2021|The New York Times|
Biden Focuses on How Spending Bill Would Lower Drug Costsnews2021-12-06T23:13:31+00:00December 6th, 2021|The New York Times|
